Apotex Metformin Recall Lawsuit

What’s the Problem?

This recall affects 100-count bottles of 500 mg Metformin Hydrochloride Extended-Release Tablets, USP, NDC Number 60505-0260-1, according to the U.S. Food & Drug Administration (FDA).

The recalled metformin contains N-Nitrosodimethylamine (NDMA), a known environmental contaminant that has been linked to increased rates of gastric cancer, colorectal cancer, and severe liver damage.

Apotex Corp. discontinued the sale of metformin in the U.S. in Feb. 2019, and there remains only a limited quantity in circulation, according to the FDA.

If you purchased any metformin that is affected by this recall, you should stop using it and contact Apotex to arrange for a return. Anyone concerned about a potential adverse reaction to metformin should contact their physician immediately.

This recall began on May 27, 2020.

Do I Have an Apotex Metformin Recall Lawsuit?

The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Apotex Metformin Recall Lawsuits. We are handling individual litigation nationwide and currently accepting new injury and death cases in all 50 states.

If you or a loved one has been injured by recalled metformin, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.